Apremilast Impurity 30 | CAS 136285-65-9 - Request Quote
Apremilast Impurity 30
| SZ CAT No: | SZ-A051054 |
| CAS No | 136285-65-9 |
| Mol.F. | C14H18N2O6 |
| Mol.Wt. | 310.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apremilast Impurity 30 is chemically Ethyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate. Apremilast Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Apremilast Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apremilast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 136285-65-9
Purchase 136285-65-9
Order 136285-65-9
Enquire 136285-65-9
price of 136285-65-9
136285-65-9 Supplier
136285-65-9 Manufacturer
136285-65-9 Exporter
buy high quality Apremilast Impurity 30
Purchase Apremilast Impurity 30
Apremilast Impurity 30 suppliers
Apremilast Impurity 30 manufacturers
Apremilast Impurity 30 price
Order Apremilast Impurity 30
Enquire Apremilast Impurity 30
Apremilast Impurity 30 cost
Apremilast Impurity 30 Supplier
Apremilast Impurity 30 Distributor
Apremilast Impurity 30 for Method Validation
Apremilast Reference Standard
Apremilast Impurity 30 for ANDA Filing
Apremilast Impurity 30 for Forced Degradation Studies
Apremilast Impurity 30 Identification Standards
Apremilast Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.